News

Read up on the latest news and recent information regarding cannabinoid-based medicine.

Making the Cannabis Industry SAFER for America

Making the Cannabis Industry SAFER for America

After nearly a decade of conversation and education on the Hill, the Senate Banking, Housing and Urban Affairs Committee finally held a markup on the Secure and Fair Regulation (SAFER) Banking Act. Previously known as the SAFE Banking Act, the “R” was included to...

Cannabis in Texas: A Look Ahead to Legalization and Beyond

Cannabis in Texas: A Look Ahead to Legalization and Beyond

A Uniquely Texas Approach to Cannabis The last few decades have seen the United States move forward state-by-state with the legalization of cannabis. Every state is charting its own unique path, and nowhere is this truer than with the state of Texas. The Lone Star...

Texas Takes Advantage of the 2018 Farm Bill

Texas Takes Advantage of the 2018 Farm Bill

When Texas Governor Greg Abbott signed Senate Bill 339, also known as the Texas Compassionate Use Act, into law in 2015, many Texans expressed frustration. The purpose of the act was to allow the THC treatment of illness via prescription, opening up the state’s...

Cannabis Lab Testing Problems Continue Nationwide

Cannabis Lab Testing Problems Continue Nationwide

In Maine, a laboratory released a study they conducted, finding a 17% failure rate of dangerous pesticides in cannabis samples tested. The state requires testing for adult use cannabis, but not for medical cannabis. Just under 4% of adult use samples failed a...

Lone Star Cannabis: What’s Holding Texas Back?

Lone Star Cannabis: What’s Holding Texas Back?

Adult-use cannabis has gained steam across the nation as more and more states jump on the legalization train. As of the writing of this article, 23 states have legalized adult-use while another 15 have allowed the sale of cannabis for medicinal purposes, for a total...

HHS Recommends Rescheduling Cannabis, Surprising an Entire Industry

HHS Recommends Rescheduling Cannabis, Surprising an Entire Industry

In the most unexpected development to hit the cannabis industry in years, the U.S. Department of Health and Human Services’ (HHS) Secretary Xavier Becerra shared his agency’s recommendation that, based on data and scientific analysis, cannabis, a Schedule I drug under...

The CBD Regulatory Environment in Europe: Part 4

The CBD Regulatory Environment in Europe: Part 4

This is the final piece of a four-part series discussing European cannabis regulations. Click here for Part One, here for Part Two and here for Part Three. Part Four wraps up the series below.  Where is the future of CBD heading? A review of these various...

Alternatives to Bankruptcy for Cannabis Companies: Part 3

Alternatives to Bankruptcy for Cannabis Companies: Part 3

Part 1 of this series discussed the lack of bankruptcy protections for cannabis companies, since bankruptcy in the U.S. is an exclusively federal procedure and cannabis remains illegal under federal law and proposed a number of alternative options for businesses...

The CBD Regulatory Environment in Europe: Part 3

The CBD Regulatory Environment in Europe: Part 3

This is Part Three of a four-part series discussing European cannabis regulations. Click here for Part One and here for Part Two. Part Three dives into dosage, approvals and more. Stay tuned for the final Part Four, coming next week. But does CBD harm the liver? Here,...

Congress Wants YOU To Make Safe Products.

Congress Wants YOU To Make Safe Products.

Recently, Congress requested detailed information regarding the regulation of CBD and other cannabinoids. This comes on the heels of frustration around federal inaction with regards to cannabinoid-containing products produced from Cannabis sativa L. plant extracts...

HHS Recommends DEA Reschedule Cannabis to Schedule III

HHS Recommends DEA Reschedule Cannabis to Schedule III

Massively promising news for the cannabis industry today that many are calling historic: the Department of Health and Human Services (HHS) has sent a letter to the Drug Enforcement Administration (DEA), recommending that cannabis be rescheduled from Schedule I to...

Payment Processing & CBD Products: What to Know

Payment Processing & CBD Products: What to Know

In the wake of the 2018 Farm Bill, the horizons of hemp-derived cannabis products expanded, offering nearly limitless opportunities for businesses and brands in the CBD industry to expand what they could offer to their customers. However, threading the path to...

The CBD Regulatory Environment in Europe: Part 2

The CBD Regulatory Environment in Europe: Part 2

This is Part Two of a four-part series discussing European cannabis regulations. Click here for Part One. Part Two analyzes the differences between the UK, the EU and the US. Part Three, coming next week, dives into dosage, approvals and more. Stay tuned for more. EU...

As Mastercard Exits Cannabis, There’s a Cash Opportunity

As Mastercard Exits Cannabis, There’s a Cash Opportunity

Late last month, Mastercard decided to halt their debit card transactions with cannabis dispensaries, notifying financial institutions and payment processors to stop processing purchases. This isn’t the first digital payment solution to swiftly exit the industry...

The CBD Regulatory Environment in Europe: Part 1

The CBD Regulatory Environment in Europe: Part 1

This is Part One of a four-part series discussing European cannabis regulations. Part One serves as an introduction. Part Two, coming next week, will analyze the differences between the UK, the EU and the US. Stay tuned for more. As I walk through any European...